Komipharm International Co., Ltd. announced a private placement of series 15 of Non-Guaranteed Private Placement Convertible Bonds for proceeds of KRW 15,000,000,000 on July 4, 2023. The bonds will bear zero interest rate and will mature on July 6, 2026. The bonds are convertible into 2,120,441 shares at an conversion price of KRW 7,074 per share.

The bonds will start conversion from July 6, 2024 and will end on June 6, 2026. The transaction is expected to close on July 6, 2023. The transaction was approved by the board of directors of the company.